FORMULIERUNGEN MIT GESTEUERTER FREISETZUNG, DIE EINEN SCHNELLEN EINTRITT UND EINEN SCHNELLEN ABFALL DER WIRKSAMEN ARZNEISTOFFPLASMAKONZENTRATIONEN HABEN

摘要

The invention is directed to oral modified/controlled release drug formulations which provide a rapid initial onset of effect and a prolonged duration of effect. Preferably, the peak concentration is lower than that provided by the reference standard for immediate release formulations of the drug, and the duration of effect falls rapidly at the end of the dosing interval.